Business Context and Reporting Period
Company: InspireMD, Inc. (NSPR)
Filing Type: Form 8-K (Current Report)
Date of Report: November 12, 2024
Reporting Period Covered: This filing serves as a Regulation FD disclosure announcing financial and operating results for the three and nine months ended September 30, 2024. The detailed metrics are contained in the attached press release (Exhibit 99.1) and are not explicitly listed in the 8-K text itself.
Key Financial Metrics
The provided 8-K text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. It references a press release (Exhibit 99.1) where these figures are detailed. Investors must refer to the attached exhibit for quantitative data.
Material Changes
The filing does not explicitly detail material changes versus prior periods within the text body. It indicates that the company has issued a press release containing these comparisons for the three and nine months ended September 30, 2024.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the issuance of a press release regarding recent highlights and results but does not include specific guidance, outlook statements, or risk factors in the 8-K text.
Legal Disclaimer: The information furnished under Item 7.01, including the press release, is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section unless expressly incorporated by reference.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the three and nine months ended September 30, 2024.
- Verify year-over-year and quarter-over-quarter growth rates detailed in the attached press release.
- Check for any updated forward-looking guidance or operational milestones mentioned in the press release.
- Confirm the company's liquidity position and debt obligations as disclosed in the full press release.